Show simple item record

dc.contributor.authorKlokkaris, A
dc.contributor.authorMigdalska-Richards, A
dc.date.accessioned2024-06-07T08:20:54Z
dc.date.issued2024-06-03
dc.date.updated2024-06-06T22:43:42Z
dc.description.abstractParkinson’s disease is a progressive neurodegenerative disorder, predominantly of the motor system. Although some genetic components and cellular mechanisms of Parkinson’s have been identified, much is still unknown. In recent years, emerging evidence has indicated that nonDNA-sequence variation (in particular epigenetic mechanisms) is likely to play a crucial role in the development and progression of the disease. Here, we present an up-to-date overview of epigenetic processes including DNA methylation, DNA hydroxymethylation, histone modifications and noncoding RNAs implicated in the brain of those with Parkinson’s disease. We will also discuss the limitations of current epigenetic research in Parkinson’s disease, the advantages of simultaneously studying genetics and epigenetics, and putative novel epigenetic therapies.en_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.identifier.citationVol. 25, No. 11, article 6168en_GB
dc.identifier.grantnumber217561/Z/19/Zen_GB
dc.identifier.urihttp://hdl.handle.net/10871/136174
dc.identifierORCID: 0000-0001-6992-0751 (Migdalska-Richards, Anna)
dc.identifierResearcherID: E-4214-2018 (Migdalska-Richards, Anna)
dc.language.isoenen_GB
dc.publisherMDPIen_GB
dc.rights© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).en_GB
dc.subjectepigeneticsen_GB
dc.subjectParkinson’s diseaseen_GB
dc.subjectDNA methylationen_GB
dc.subjectDNA hydroxymethylationen_GB
dc.subjecthistone modificationsen_GB
dc.subjectnon-coding RNAsen_GB
dc.subjectmicroRNAsen_GB
dc.subjectepigenetic therapyen_GB
dc.titleAn overview of epigenetic changes in the Parkinson’s Disease brainen_GB
dc.typeArticleen_GB
dc.date.available2024-06-07T08:20:54Z
dc.identifier.issn1661-6596
dc.descriptionThis is the final version. Available from MDPI via the DOI in this record. en_GB
dc.descriptionData availability: This study did not generate any new data.en_GB
dc.identifier.eissn1422-0067
dc.identifier.journalInternational Journal of Molecular Sciencesen_GB
dc.relation.ispartofInternational Journal of Molecular Sciences
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2024-05-29
dcterms.dateSubmitted2024-05-05
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2024-05-29
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2024-06-07T08:15:20Z
refterms.versionFCDVoR
refterms.dateFOA2024-06-07T08:25:34Z
refterms.panelAen_GB
refterms.dateFirstOnline2024-06-03
exeter.rights-retention-statementYes


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2024 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
Except where otherwise noted, this item's licence is described as © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).